HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

human papillomavirus type 18 L1 VLP vaccine

VLP - virus-like particle; each dose consists of 80 microgm of HPV18 L1 VLP formulated with 450 microgm of amorphous aluminum hydroxyphosphate sulfate adjuvant in a buffer solution
Also Known As:
HLP18 L1 VLP vaccine
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results